Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,881 | 161 | 99.9% |
| Education | $2.56 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $878.37 | 44 | $0 (2021) |
| Daiichi Sankyo Inc. | $597.12 | 37 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $339.35 | 19 | $0 (2021) |
| Allergan, Inc. | $222.13 | 20 | $0 (2020) |
| Lilly USA, LLC | $182.12 | 9 | $0 (2021) |
| Amgen Inc. | $137.86 | 2 | $0 (2019) |
| Arbor Pharmaceuticals, Inc. | $82.02 | 6 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $73.95 | 1 | $0 (2018) |
| Promius Pharma LLC | $70.65 | 5 | $0 (2018) |
| Fidia Pharma USA Inc. | $54.13 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $46.70 | 2 | Fidia Pharma USA Inc. ($24.94) |
| 2021 | $132.64 | 9 | Collegium Pharmaceutical, Inc. ($88.21) |
| 2020 | $350.43 | 23 | Collegium Pharmaceutical, Inc. ($113.90) |
| 2019 | $869.23 | 61 | BioDelivery Sciences International, Inc. ($173.20) |
| 2018 | $1,072 | 52 | Daiichi Sankyo Inc. ($403.02) |
| 2017 | $411.75 | 15 | Collegium Pharmaceutical, Inc. ($298.71) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/11/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.85 | General |
| Category: Opioid Analgesic | ||||||
| 10/19/2021 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Opioid Analgesic | ||||||
| 10/13/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Chronic Pain | ||||||
| 08/30/2021 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: OSTEOARTHRITIS | ||||||
| 08/25/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Opioid Analgesic | ||||||
| 07/26/2021 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $14.42 | General |
| Category: Opioid Analgesic | ||||||
| 06/16/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Neuroscience | ||||||
| 04/28/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Opioid Analgesic | ||||||
| 03/24/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | — | Food and Beverage | In-kind items and services | $17.46 | General |
| 12/08/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.54 | General |
| Category: Opioid Analgesic | ||||||
| 11/18/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/11/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Opioid Analgesic | ||||||
| 11/09/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Neuroscience | ||||||
| 10/22/2020 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Opioid Analgesic | ||||||
| 10/14/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Opioid Analgesic | ||||||
| 09/29/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/23/2020 | RedHill Biopharma Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Opioid Antagonist | ||||||
| 09/22/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/26/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Chronic Pain | ||||||
| 08/17/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.63 | General |
| Category: Opioid Analgesic | ||||||
| 08/10/2020 | Arbor Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Sleep | ||||||
| 08/05/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Chronic Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,775 | 18,066 | $1.5M | $359,301 |
| 2022 | 13 | 2,208 | 3,973 | $618,220 | $304,865 |
| 2021 | 16 | 2,403 | 5,317 | $712,503 | $357,534 |
| 2020 | 14 | 1,703 | 3,649 | $545,543 | $276,560 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 513 | 619 | $139,275 | $69,760 | 50.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 307 | 605 | $101,035 | $50,690 | 50.2% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 363 | 388 | $58,976 | $28,292 | 48.0% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 200 | 212 | $45,792 | $22,571 | 49.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 48 | $15,888 | $7,542 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 103 | $16,995 | $7,458 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 65 | $14,300 | $6,678 | 46.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 75 | 76 | $13,072 | $6,538 | 50.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 83 | 136 | $8,704 | $4,389 | 50.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 13 | 34 | $6,800 | $2,792 | 41.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2022 | 54 | 54 | $8,100 | $2,341 | 28.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 17 | 29 | $3,219 | $1,658 | 51.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 505 | 1,752 | $203,232 | $105,272 | 51.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 413 | 446 | $100,350 | $51,010 | 50.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 314 | 501 | $83,667 | $43,116 | 51.5% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 327 | 338 | $73,008 | $36,813 | 50.4% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2021 | 17 | 1,200 | $60,000 | $28,794 | 48.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 146 | 156 | $51,636 | $26,069 | 50.5% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2021 | 224 | 231 | $35,112 | $17,273 | 49.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 92 | $20,240 | $9,542 | 47.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 87 | 89 | $15,308 | $7,925 | 51.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 61 | 124 | $13,764 | $7,264 | 52.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 83 | $13,695 | $5,905 | 43.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 31 | $8,370 | $4,685 | 56.0% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 21 | 60 | $12,000 | $4,600 | 38.3% |
About Dr. John Mikuzis, DO
Dr. John Mikuzis, DO is a Physical Medicine & Rehabilitation healthcare provider based in Shorewood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629048178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mikuzis, DO has received a total of $2,883 in payments from pharmaceutical and medical device companies, with $46.70 received in 2022. These payments were reported across 162 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,881).
As a Medicare-enrolled provider, Mikuzis has provided services to 9,089 Medicare beneficiaries, totaling 31,005 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Shorewood, IL
- Active Since 01/26/2006
- Last Updated 12/14/2009
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1629048178
Products in Payments
- Morphabond ER (Drug) $548.32
- Xtampza ER (Drug) $441.21
- XTAMPZA (Drug) $310.52
- BOTOX (Biological) $192.25
- BELBUCA (Drug) $189.64
- EMGALITY (Drug) $182.12
- Aimovig (Biological) $137.86
- BUNAVAIL 2.1 mg 30-count box (Drug) $132.25
- Horizant (Drug) $82.02
- DIFICID (Drug) $73.95
- Zembrace (Drug) $70.65
- Nucynta (Drug) $70.41
- Movantik (Drug) $61.79
- BOTOX THERAPEUTIC (Biological) $51.64
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $44.42
- HYMOVIS (Device) $39.52
- XTAMPZAER (Drug) $35.20
- Gralise (Drug) $28.12
- Zembrace SymTouch Sumatriptan Injection (Drug) $21.80
- XTAMPZA ER (Drug) $18.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Shorewood
Trinh Truong, Md, MD
Physical Medicine & Rehabilitation — Payments: $9,903
Robert Yee, Md, MD
Physical Medicine & Rehabilitation — Payments: $25.56
Gary Golden, D.o, D.O
Physical Medicine & Rehabilitation